Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aveeno is a prominent consumer healthcare brand specializing in dermatological skincare products formulated with natural ingredients. Founded in 1945 by the Musher brothers, the company is best known for its pioneering use of colloidal oatmeal to treat various skin conditions. Aveeno's product portfolio includes clinically proven solutions for eczema, psoriasis, sensitive skin, and daily hydration, marketed under its Active Naturals branding. The company was acquired by Johnson & Johnson in 1999 and is currently a key brand within Kenvue, the independent consumer health company spun off from J&J. Aveeno maintains strong partnerships with dermatologists and health organizations like the National Eczema Association to validate its therapeutic claims. Its research focuses on the skin microbiome and the restoration of the skin's natural moisture barrier.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aveeno.